[{"Assets_0_Q1_USD":1556006.0,"CommonStockSharesOutstanding_0_Q1_shares":12549870.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-1670983.0,"NetIncomeLoss_1_Q1_USD":-3380093.0,"StockholdersEquity_0_Q1_USD":-8740368.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181113"}]